Our findings are in line with previous evidence from animal models that immunization against SARS-CoV-2 by vaccination appeared to reduce the severity of pathogenesis, especially with regard to severe lung disease, while viral RNA persisted in nasal swabs (Van Doremalen et al., 2020, Vogel et al., 2021). Recently, Amit et al. (2021) published results on a clinical trial on healthcare workers using vaccine BNT162b2 that demonstrated substantial early reductions in SARS-CoV-2 infection and symptomatic COVID-19 rates following administration of the first vaccine dose
You're getting there.
I see.
We're going to leave out key data like, ummm, idk, whether these "vaccinated" individuals already had "covid-19", thereby natural immunity.
Then ignore 74% of new infections in Massachusetts were fully vaccinated.
Then ignore fully "vaccinated" countries inundated with this migratory pneumonia.
Let's just use half science.
By all means, this 7-month vaccine trial has been extraordinarily successful, despite more deaths than all vaccines combined over 30 years.
And 2 million severe adverse reactions by Europe alone.
And no antibody tests.
For full disclosure, can we take a look at your robinhood portfolio?
www.ncbi.nlm.nih.gov
@Splinty 
